Drug Supply Chain: Kim Monk analyzes 20+ reform concepts, from carrots (tax credits, financial incentives) to sticks (tariffs, bans on certain imports, Buy American mandates). Comprehensive reform unlikely in 2020 but minor Covid-tied provision possible. $MRK $NVS $GSK $JNJ $PFE